|
To,
Sun Pharma Laboratories Limited
Sun House,
Mumbai
Subject : A multicentre, retrospective, observational, cross-sectional, survey study to analyse the role of Fluticasone Furoate and Vilanterol Powder for Inhalation in Asthma.
In response to your letter dated …………………., I agree to participate in the study as outlined by you.
I understand that:
-
You will provide me with a copy of the data collection plan and …… DCFs.
-
All the data shared by me will be retrospective in nature.
-
The patient’s identity will not be disclosed in the DCF.
My personal details are given below for accuracy of your records.
|